Robotic vs. minimally invasive mitral valve repair: A 5-year comparison of surgical outcomes
- PMID: 35989503
- DOI: 10.1111/jocs.16849
Robotic vs. minimally invasive mitral valve repair: A 5-year comparison of surgical outcomes
Abstract
Background: Minimally invasive mitral valve repair (MVr) is commonly performed. Data on the outcomes of robotic MVr versus nonrobotic minimally invasive MVr are lacking. We sought to compare the short-term and mid-term outcomes of robotic and nonrobotic MVr.
Methods: We reviewed all patients who underwent robotic MVr (n = 424) or nonrobotic MVr via right mini-thoracotomy (n = 86) at Mayo Clinic, Rochester, MN, from January 2015 to February 2020. Data on baseline and operative characteristics, operative and long-term outcomes were analyzed. Patients were matched 1:1 using propensity scores.
Results: Sixty-nine matched pairs were included in the study. The median age was 59 years (interquartile range [IQR]: 54-69) and 75% (n = 103) were male. Baseline characteristics were similar after matching. Robotic and nonrobotic MVr had similar operative characteristics, except that robotic had longer cross-clamp times (57 [48-67] vs. 47 [37-58] min, p < .001) and more P2 resections (83% vs. 68%, p = .05) compared to nonrobotic MVr. There was no difference in operative outcomes between groups. Hospital stay was shorter after robotic MVr (4 [3-4] vs. 4 [4-6] days, p = .003). After a median follow-up of 3.3 years (IQR, 2.1-4.5), there was no mortality in either group, and there was no difference in freedom from mitral valve reoperations between robotic and nonrobotic MVr (5 years: 97.1% vs. 95.7%, p = .63). Follow-up echocardiogram analysis predicted excellent freedom from recurrent moderate-or-severe mitral regurgitation at 3 years after robotic and nonrobotic MVr (90% vs. 92%, p = .18, respectively).
Conclusions: Both short-term and mid-term outcomes of robotic and nonrobotic minimally invasive mitral repair surgery are comparable.
Keywords: valve repair/replacement.
© 2022 Wiley Periodicals LLC.
References
REFERENCES
-
- Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation. 2021;143(5):72. doi:10.1161/cir.0000000000000923
-
- David TE, David CM, Tsang W, Lafreniere-Roula M, Manlhiot C. Long-term results of mitral valve repair for regurgitation due to leaflet prolapse. J Am Coll Cardiol. 2019;74(8):1044-1053. doi:10.1016/j.jacc.2019.06.052
-
- Lazam S, Vanoverschelde J-L, Tribouilloy C, et al. Twenty-year outcome after mitral repair versus replacement for severe degenerative mitral regurgitation. Circulation. 2017;135(5):410-422. doi:10.1161/circulationaha.116.023340
-
- Karagoz HY, Bayazit K, Battaloglu B, et al. Minimally invasive mitral valve surgery: the subxiphoid approach. Ann Thorac Surg. 1999;67(5):1328-1332. doi:10.1016/s0003-4975(99)00059-4
-
- Mishra YK, Malhotra R, Mehta Y, Sharma KK, Kasliwal RR, Trehan N. Minimally invasive mitral valve surgery through right anterolateral minithoracotomy. Ann Thorac Surg. 1999;68(4):1520-1524. doi:10.1016/s0003-4975(99)00963-7
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
